Maravai LifeSciences Holdings, Inc.
MRVI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,430,813 | $1,644,946 | $3,583,580 | $9,156,404 |
| - Cash | $322,399 | $574,962 | $632,138 | $551,272 |
| + Debt | $376,692 | $610,967 | $585,262 | $575,219 |
| Enterprise Value | $1,485,106 | $1,680,951 | $3,536,704 | $9,180,351 |
| Revenue | $259,185 | $288,945 | $883,001 | $799,240 |
| % Growth | -10.3% | -67.3% | 10.5% | – |
| Gross Profit | $108,309 | $140,202 | $714,044 | $658,679 |
| % Margin | 41.8% | 48.5% | 80.9% | 82.4% |
| EBITDA | -$156,917 | $712,409 | $609,989 | $585,777 |
| % Margin | -60.5% | 246.6% | 69.1% | 73.3% |
| Net Income | -$144,846 | -$119,029 | $220,205 | $182,037 |
| % Margin | -55.9% | -41.2% | 24.9% | 22.8% |
| EPS Diluted | -1.05 | -0.9 | 1.67 | 1.56 |
| % Growth | -16.7% | -153.9% | 7.1% | – |
| Operating Cash Flow | $7,465 | $126,224 | $535,977 | $368,570 |
| Capital Expenditures | -$29,658 | -$65,553 | -$17,090 | -$14,850 |
| Free Cash Flow | -$22,193 | $60,671 | $518,887 | $353,720 |